Literature DB >> 9648051

Pituitary apoplexy in acromegaly, a long-term follow-up study in two patients.

F Roelfsema1, G van den Berg, H van Dulken, J D Veldhuis, S M Pincus.   

Abstract

Pituitary apoplexy is a serious complication in about 3% of patients with a pituitary adenoma. Very often, the diagnosis of a functioning or non-functioning adenoma is made in retrospect. In this report, we describe two patients in whom the diagnosis of acromegaly was made before the apoplexy. In one patient, surgical intervention was necessary because of remaining clinical and biochemical activity; in the other patient conservative follow-up was pursued. Seven and nine years after apoplexy, respectively, the patients were clinically and biochemically in remission. During the follow-up, three and five years after apoplexy, respectively, the patients underwent a 10-min venous sampling procedure for 24 hours, and the GH secretory profile was investigated with multiparameter deconvolution analysis and by approximate entropy (ApEn), a scale- and model-independent regularity measure. The deconvolution analysis revealed an increased basal (nonpulsatile) GH secretion rate, while the total 24 h secretion rate was normal compared with 13 healthy male control subjects. ApEn was much larger for each patient than for any control subject value, indicating markedly more irregular GH secretion. We hypothesize that these subtle abnormalities are caused by non-specific damage as a result of vascular insult, leading to abnormal vascular supply, or abnormal autocrine and paracrine GH regulation within the remaining gland.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9648051     DOI: 10.1007/BF03350332

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  19 in total

1.  Regression of acromegaly following pituitary apoplexy.

Authors:  P J Dunn; R A Donald; E A Espiner
Journal:  Aust N Z J Med       Date:  1975-08

2.  Deconvolution analysis of hormone data.

Authors:  J D Veldhuis; M L Johnson
Journal:  Methods Enzymol       Date:  1992       Impact factor: 1.600

3.  Pituitary apoplexy and its effect on vision.

Authors:  R M McFadzean; D Doyle; R Rampling; E Teasdale; G Teasdale
Journal:  Neurosurgery       Date:  1991-11       Impact factor: 4.654

4.  Physiological time-series analysis: what does regularity quantify?

Authors:  S M Pincus; A L Goldberger
Journal:  Am J Physiol       Date:  1994-04

5.  Pituitary apoplexy treated by transsphenoidal surgery. A clinicopathological and immunocytochemical study.

Authors:  M J Ebersold; E R Laws; B W Scheithauer; R V Randall
Journal:  J Neurosurg       Date:  1983-03       Impact factor: 5.115

6.  Hemorrhagic pituitary adenomas: clinicopathological features and surgical treatment.

Authors:  B Fraioli; V Esposito; L Palma; G Cantore
Journal:  Neurosurgery       Date:  1990-11       Impact factor: 4.654

7.  Reduced disorderliness of growth hormone release in biochemically inactive acromegaly after pituitary surgery.

Authors:  G van den Berg; S M Pincus; M Frölich; J D Veldhuis; F Roelfsema
Journal:  Eur J Endocrinol       Date:  1998-02       Impact factor: 6.664

8.  Pituitary apoplexy: its incidence and clinical significance.

Authors:  S Wakai; T Fukushima; A Teramoto; K Sano
Journal:  J Neurosurg       Date:  1981-08       Impact factor: 5.115

9.  Augmented growth hormone (GH) secretory burst frequency and amplitude mediate enhanced GH secretion during a two-day fast in normal men.

Authors:  M L Hartman; J D Veldhuis; M L Johnson; M M Lee; K G Alberti; E Samojlik; M O Thorner
Journal:  J Clin Endocrinol Metab       Date:  1992-04       Impact factor: 5.958

10.  Growth hormone secretion in recently operated acromegalic patients.

Authors:  G van den Berg; M Frölich; J D Veldhuis; F Roelfsema
Journal:  J Clin Endocrinol Metab       Date:  1994-12       Impact factor: 5.958

View more
  1 in total

1.  Limited effects of growth hormone replacement in patients with GH deficiency during long-term cure of acromegaly.

Authors:  Agatha A van der Klaauw; Jeroen J Bax; Ferdinand Roelfsema; Marcel P M Stokkel; Gabe B Bleeker; Nienke R Biermasz; Johannes W A Smit; Johannes A Romijn; Alberto M Pereira
Journal:  Pituitary       Date:  2009-06-12       Impact factor: 4.107

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.